Fidelity Investments’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
PCM
Fidelity Investments's PLSE Position: Q2 2026 in Review
Fidelity Investments reduced its Pulse Biosciences (PLSE) stake by 1.4% in Q2 2026, selling an estimated $4.77K and leaving 13,948 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #3389.
Fidelity Investments first reported a position in PLSE in Q1 2022 and has held it in 15 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.
- Fidelity Investments held 13,948 shares of Pulse Biosciences worth $387K as of Q2 2026.
- Fidelity Investments sold 202 Pulse Biosciences shares in Q2 2026, an estimated $4.77K.
- Pulse Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3389 holding.
- Fidelity Investments first reported a position in Pulse Biosciences in Q1 2022 and has held it in 15 quarters since.
- 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.